The PL Law Group, PLLC
Method to inhibit cancer targeting CD24
The present invention relates to a method to inhibit cancer by targeting CD24, more precisely a method to inhibit cancer by using CD24 expressed in most cancer cells as a target of an antibody therapeutic agent or by inhibiting the interaction between CD24 and P-selectin. CD24 is over-expressed in most cancer cells and CD24 accumulated in cytoplasm accelerates metastasis. Therefore, the method to inhibit cancer of the invention by targeting CD24 can be effectively used for the treatment of cancer by inhibiting the progress of various cancers over-expressing CD24.
SNU R&DB Foundation
A C A A C A A A C A C A A A C
A61K C07K A61K A61K C12N A61K A61K A61K C07K A61P C07K A61K A61K A61K C12N
inventional inventional inventional inventional inventional inventional inventional inventional additional inventional additional additional additional inventional additional
Young Woo Young Kee Kyoung Yoon-La Seung Hyun
Park Shin Song Choi Lee